Read the latest news and updates from NCATS.
National Center for Advancing Translational Sciences | Catalyzing Innovation
Volume 05 • Issue 01 • January 28, 2016

Director's Message

Dr. Chris Austin with NCATS robot

Some of the most common New Year’s resolutions are health-related, and NCATS is no exception — but we aim for resolutions that will be more durable than average, since evidence shows that most resolutions are broken by February! 

Read more

Connect with NCATS


Top Story

NIH Twitter Chat on Rare Diseases

NIH, NCATS and other experts will host a pre-event Twitter chat on Feb. 22, 2016, from 2:00 – 3:00 p.m. ET, to answer questions and discuss the latest rare diseases research advancements. Join Drs. Collins and Austin for the discussion, and use #NIHChat to participate in the conversation. Read more >

Facebook logo
Twitter logo


Plate washer technology in NCATS’ laboratory

Growth Continues for NCATS SBIR Awardee

IonField Systems worked with NCATS to develop a plasma wash to reuse high-throughput screening plates. This company recently sold its first PlasmaKnife™ plate cleaner to a major pharmaceutical company, making the goal of the Small Business Innovation Research program to commercialize innovative new technologies a reality. Read more >

Twitter logo


Cerebellum of a brain affected by NPC

FDA Grants NPC Treatment Breakthrough Status 

The Food and Drug Administration granted Vtesse, Inc., breakthrough therapy designation status for drug candidate VTS-270 for treatment of ‪‎Niemann-Pick disease type C. NCATS and the Eunice Kennedy Shriver National Institute of Child Health and Human Development, in close collaboration with Vtesse, patients and patient advocacy groups, developed VTS-270. Read more >

Twitter logo


Researcher collects samples for toxicity testing

NCATS Joins Challenge to Improve Toxicity Data

The Environmental Protection Agency, NCATS, and NIH’s National Toxicology Program representatives recently announced a new data challenge to include up to $1 million in awards to improve the relevance and predictivity of toxicity data generated from automated chemical screening. Read more >

Facebook logo
Twitter logo


Portraits of Drs. Gopal-Srivastava and Inglese

Meet More of NCATS' Staff

Rashmi Gopal-Srivastava, M.Sc., Ph.D., is the director of the Extramural Research Program in the NCATS Office of Rare Diseases Research. James Inglese, Ph.D., directs NCATS’ Assay Development and Screening Technology laboratory within the Division of Pre-Clinical Innovation. Learn more about these and many other NCATS staff members via NCATS’ Staff Profiles. Read more > 

Twitter logo



Don't miss the deadline to comment on NCATS' strategic planning process.


Rare Disease Day at NIH begins at 8:30 a.m. in Masur Auditorium, Building 10 on the NIH campus.

Collaborate with NCATS Scientists

Research Opportunities and Announcements Highlights

More From NCATS 

NCATS in the News

like us on Facebook |  follow us on Twitter |  forward to a friend |  watch us on YouTube

National Center for Advancing Translational Sciences
National Institutes of Health
6701 Democracy Boulevard, 9th Floor
Bethesda, MD 20892

Add us to your address book
NIH, National Center for Advancing Translational Sciences